C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/70 (2006.01) A61K 39/21 (2006.01) A61K 39/42 (2006.01) C07K 7/08 (2006.01) C07K 14/16 (2006.01) C07K 14/725 (2006.01) C07K 16/10 (2006.01) C07K 16/28 (2006.01) G01N 33/566 (2006.01) G01N 33/569 (2006.01) A61K 38/00 (2006.01) A61K 39/00 (2006.01) F02B 75/02 (2006.01)
Patent
CA 2069507
The present invention provides therapy and prophylaxis against HIV-induced AIDS, as well as methods for ascertaining the susceptibility of an individual to HIV-induced AIDS, the invention being based on the discovery that AIDS results from gp120 of HIV mimicking the antigen-presenting component of the immune system, thereby spuriously activating certain + T cells in susceptible individuals, leading to a condition similar to graft versus host disease, the condition being treatable by eliminating the responsible T cells, for example.
Bountiff Lynne
Dalgleish Angus G.
Habeshaw John A.
Hounsell Elizabeth
Peptech (uk) Limited
Sim & Mcburney
LandOfFree
Aids therapy and vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aids therapy and vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aids therapy and vaccine will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1372545